Cargando…
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
BACKGROUND: Acute T-cell lymphoblastic leukaemia (T-ALL) is an aggressive disorder derived from immature thymocytes. The variability observed in clinical responses on this type of tumours to treatments, the high toxicity of current protocols and the poor prognosis of patients with relapse or refract...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815385/ https://www.ncbi.nlm.nih.gov/pubmed/31655559 http://dx.doi.org/10.1186/s12885-019-6209-9 |